Earnings Per Share
Income per common share is calculated using earnings for the year divided by the weighted average number of shares outstanding during the year. Using the treasury stock method, diluted income per share amounts are calculated giving effect to the potential dilution that would occur if securities or other contracts to issue common shares were exercised or converted to common shares by assuming the proceeds received from the exercise of stock options and the vesting of RSUs are used to purchase common shares at the prevailing market rate.

The following reflects the earnings and share data used in the basic and diluted earnings per share computations:
Year Ended December 31,
202520242023
Numerator - basic and diluted:
Net income attributable to Viemed Healthcare, Inc.
$14,934 $11,265 $10,243 
Denominator:
Basic weighted average number of common shares38,895,228 38,754,893 38,354,071 
Diluted weighted average number of shares40,823,823 40,805,085 40,378,922 
Basic earnings per share$0.38 $0.29 $0.27 
Diluted earnings per share$0.37 $0.28 $0.25 
Denominator calculation from basic to diluted:
Basic weighted average number of common shares38,895,228 38,754,893 38,354,071 
Stock options and other dilutive securities1,928,595 2,050,192 2,024,851 
Diluted weighted average number of shares40,823,823 40,805,085 40,378,922 

Anti-dilutive shares excluded from the calculation consisted of dilutive employee stock options and RSUs that were de minimis in all periods presented.

Historical Timeline

Fiscal YearFiled
2025Mar 4, 2026Showing above
2024Mar 10, 2025
2023Mar 6, 2024
2022Mar 2, 2023
2021Mar 7, 2022
2020Mar 3, 2021
2019Mar 4, 2020

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.